SPONSOR
British Columbia Cancer Agency
Total Trials
2
Recruiting
2
Phases
Phase 2
NCT06200974
Recruiting
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Localized Prostate Carcinoma
NCT04787289 Phase 2
Recruiting
A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Ovarian Cancer